SCHEMBL6540229

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL6541483	0.92	CA1 (0.56)	HTR6CA1CA2MPOBCHE
	SCHEMBL6541181	0.90	CA1 (0.58)	CA1CA2MPOSIGMAR1BCHE
	SCHEMBL6677121	0.89	CA1 (0.50)	CA1CA2MPOSIGMAR1BCHE
	SCHEMBL3763353	0.84	HTR6 (0.59)	HTR6
	SCHEMBL3763771	0.84	HTR6 (0.59)	HTR6
	SCHEMBL6539919	0.83	HTR6 (0.51)	HTR6CA1CA2MPOBCHE
	SCHEMBL6540205	0.81	CA1 (0.69)	CA1CA2BCHECA12CA4
	SCHEMBL6541401	0.81	CA1 (0.59)	HTR6CA1CA2BCHECA12
	SCHEMBL6541651	0.79	CA1 (0.63)	HTR6CA1CA2BCHECA12
	SCHEMBL6676685	0.79	CHRM2 (0.51)	CA1CA2BCHECA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.